Loading viewer...
earnings
Format: PDF earnings
Perrigo Company's first quarter 2023 quarterly update presented on May 9, 2023, covering financial performance and strategic initiatives. The presentation discusses forward-looking statements related to supply chain impacts, regulatory approvals including over-the-counter contraceptives, and integration of recent acquisitions including HRA Pharma and Nestlé's Gateway infant formula business. Key risk factors and non-GAAP measures are addressed throughout the quarterly report.
case-study
earnings
7 Pages
Acorda Therapeutics
Ormat Technologies Q2 2023 Earnings Call
earningsearnings
34 Pages
Ormat Technologies
Freeport-McMoRan Q3 2016 Earnings Conference Presentation
earningsearnings
29 Pages
Freeport-McMoRan Inc.
Teva Pharmaceutical Q4 2022 Earnings Results
earningsearnings
46 Pages
Teva Pharmaceutical Industries Ltd.